Voors AA - Search Results

1

A single dose of erythropoietin in ST-elevation myocardial infarction.

Voors AA, Belonje AM, Zijlstra F, Hillege HL, Anker SD, Slart RH, Tio RA, van 't Hof A, Jukema JW, Peels HO, Henriques JP, Ten Berg JM, Vos J, van Gilst WH, van Veldhuisen DJ; HEBE III Investigators. Voors AA, et al. Eur Heart J. 2010 Nov;31(21):2593-600. doi: 10.1093/eurheartj/ehq304. Epub 2010 Aug 29. Eur Heart J. 2010. PMID: 20802250 Clinical Trial.

2

Approaches to statistical analysis of repeated echocardiographic measurements after myocardial infarction and its relation to heart failure: Application of a random-effects model.

de Kam PJ, Voors AA, Brouwer J, St John Sutton M, van Gilst WH. de Kam PJ, et al. Among authors: voors aa. Eur J Heart Fail. 2002 Jun;4(3):277-82. doi: 10.1016/s1388-9842(02)00003-x. Eur J Heart Fail. 2002. PMID: 12034152 Free article. Clinical Trial.

3

Angiotensin receptors in the cardiovascular system.

Wagenaar LJ, Voors AA, Buikema H, van Gilst WH. Wagenaar LJ, et al. Among authors: voors aa. Can J Cardiol. 2002 Dec;18(12):1331-9. Can J Cardiol. 2002. PMID: 12518185 Review.

4

Differences between angiotensin-converting enzyme inhibition and angiotensin II-AT1 antagonism on angiotensin-mediated responses in human internal mammary arteries.

Voors AA, Oosterga M, Buikema H, Mariani M, Grandjean JG, van Gilst WH. Voors AA, et al. J Cardiovasc Pharmacol. 2003 Feb;41(2):178-84. doi: 10.1097/00005344-200302000-00005. J Cardiovasc Pharmacol. 2003. PMID: 12548077

5

Functional antagonism of different angiotensin II type I receptor blockers in human arteries.

Wagenaar LJ, Voors AA, Buikema H, van Buiten A, Lübeck RH, Boonstra PW, van Veldhuisen DJ, van Gilst WH. Wagenaar LJ, et al. Among authors: voors aa. Cardiovasc Drugs Ther. 2002 Jul;16(4):311-6. doi: 10.1023/a:1021729909456. Cardiovasc Drugs Ther. 2002. PMID: 12652100

6

Short-term statin therapy and cardiac function and symptoms in patients with idiopathic dilated cardiomyopathy.

van der Harst P, Voors AA, van Veldhuisen DJ. van der Harst P, et al. Among authors: voors aa. Circulation. 2004 Feb 10;109(5):e34; author reply e34. doi: 10.1161/01.CIR.0000115211.60667.A6. Circulation. 2004. PMID: 14769695 No abstract available.

7

Erythropoietin in cardiovascular diseases.

van der Meer P, Voors AA, Lipsic E, van Gilst WH, van Veldhuisen DJ. van der Meer P, et al. Among authors: voors aa. Eur Heart J. 2004 Feb;25(4):285-91. doi: 10.1016/j.ehj.2003.11.017. Eur Heart J. 2004. PMID: 14984916 Review.

8

Prognostic value of plasma erythropoietin on mortality in patients with chronic heart failure.

van der Meer P, Voors AA, Lipsic E, Smilde TD, van Gilst WH, van Veldhuisen DJ. van der Meer P, et al. Among authors: voors aa. J Am Coll Cardiol. 2004 Jul 7;44(1):63-7. doi: 10.1016/j.jacc.2004.03.052. J Am Coll Cardiol. 2004. PMID: 15234408 Free article.

9

Prognostic importance of renal function in patients with early heart failure and mild left ventricular dysfunction.

Smilde TD, Hillege HL, Voors AA, Dunselman PH, Van Veldhuisen DJ. Smilde TD, et al. Among authors: voors aa. Am J Cardiol. 2004 Jul 15;94(2):240-3. doi: 10.1016/j.amjcard.2004.03.075. Am J Cardiol. 2004. PMID: 15246913

10

Intensive versus moderate lipid lowering with statins after acute coronary syndromes.

van der Harst P, Voors AA, van Veldhuisen DJ. van der Harst P, et al. Among authors: voors aa. N Engl J Med. 2004 Aug 12;351(7):714-7; author reply 714-7. doi: 10.1056/NEJM200408123510719. N Engl J Med. 2004. PMID: 15306676 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

815 results

Search Page

Filters